SCHEMBL6448599

SCHEMBL6448599

CCc1ccccc1CNC(=O)c1c(C)c(-c2ccccc2)nc2ccccc12

nearest known ligand 0.67

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.67
HPGD P15428 1/20 0.67
TP53 P04637 2/20 0.64
LMNA P02545 2/20 0.64
MAPT P10636 1/20 0.61
TACR3 P29371 6/20 0.60
TACR2 P21452 3/20 0.60
TSHR P16473 2/20 0.60
MEN1 O00255 1/20 0.60
CYP1A2 P05177 1/20 0.60
CYP3A4 P08684 1/20 0.60
CYP2C9 P11712 1/20 0.60
NFKB1 P19838 1/20 0.60
MAPK1 P28482 1/20 0.60
CYP2C19 P33261 1/20 0.60
BLM P54132 1/20 0.60
PMP22 Q01453 1/20 0.60
KMT2A Q03164 1/20 0.60
ATM Q13315 1/20 0.60
SMN1; SMN2 Q16637 1/20 0.60

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6448666 0.88 TACR3 (0.60) ALDH1A1HPGDTP53LMNAMAPT
SCHEMBL6449830 0.88 TACR3 (0.61) ALDH1A1HPGDTP53LMNATACR3
SCHEMBL6447781 0.88 ALDH1A1 (0.73) ALDH1A1HPGDTP53LMNAMAPT
SCHEMBL6451528 0.87 LMNA (0.66) ALDH1A1HPGDTP53LMNAMAPT
SCHEMBL8226622 0.87 ALDH1A1 (0.64) ALDH1A1HPGDTP53LMNAMAPT
SCHEMBL6448792 0.87 LMNA (0.65) ALDH1A1HPGDTP53LMNAMAPT
SCHEMBL6451847 0.86 ALDH1A1 (0.55) ALDH1A1HPGDTP53LMNAMAPT
SCHEMBL14523182 0.84 LMNA (0.79) ALDH1A1HPGDTP53LMNAMAPT
SCHEMBL6450548 0.84 TACR3 (0.63) ALDH1A1HPGDTP53LMNAMAPT
Hydrochloric Acid SCHEMBL6449066 0.83 TACR3 (0.62) ALDH1A1HPGDTP53LMNATACR3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1517708-A1 COMBINATION TREATMENT FOR DEPRESSION AND ANXIETY BY NK1 AND NK3 ANTAGONISTS Pfizer Products Inc. (US) 2005-03-30 EP claimed
WO-2004000355-A1 COMBINATION TREATMENT FOR DEPRESSION AND ANXIETY BY NK1 AND NK3 ANTAGONISTS PFIZER PRODUCTS INC. (US) 2003-12-31 WO claimed
EP-1517708-A1 COMBINATION TREATMENT FOR DEPRESSION AND ANXIETY BY NK1 AND NK3 ANTAGONISTS Pfizer Products Inc. (US) 2005-03-30 EP disclosed
WO-2004000355-A1 COMBINATION TREATMENT FOR DEPRESSION AND ANXIETY BY NK1 AND NK3 ANTAGONISTS PFIZER PRODUCTS INC. (US) 2003-12-31 WO disclosed